A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 182,644 shares of MRNA stock, worth $12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
182,644
Previous 184,291 0.89%
Holding current value
$12 Million
Previous $19.6 Million 10.44%
% of portfolio
0.07%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$101.21 - $166.61 $166,692 - $274,406
-1,647 Reduced 0.89%
182,644 $21.7 Million
Q1 2024

May 03, 2024

SELL
$85.37 - $115.44 $115,932 - $156,767
-1,358 Reduced 0.73%
184,291 $19.6 Million
Q4 2023

Jan 24, 2024

SELL
$69.51 - $104.43 $57,206 - $85,945
-823 Reduced 0.44%
185,649 $18.5 Million
Q3 2023

Oct 23, 2023

SELL
$96.41 - $126.61 $238,903 - $313,739
-2,478 Reduced 1.31%
186,472 $19.3 Million
Q2 2023

Jul 25, 2023

SELL
$118.5 - $160.53 $402,781 - $545,641
-3,399 Reduced 1.77%
188,950 $23 Million
Q1 2023

May 17, 2023

BUY
$135.66 - $197.02 $25.3 Million - $36.7 Million
186,441 Added 3155.74%
192,349 $29.5 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $25 Million - $36.3 Million
-184,483 Reduced 96.9%
5,908 $907 Million
Q4 2022

Feb 09, 2023

SELL
$118.38 - $210.04 $1.79 Million - $3.18 Million
-15,138 Reduced 7.37%
190,391 $34.2 Million
Q3 2022

Nov 04, 2022

SELL
$118.07 - $194.18 $407,695 - $670,503
-3,453 Reduced 1.65%
205,529 $24.3 Million
Q2 2022

Aug 10, 2022

SELL
$117.13 - $176.59 $465,240 - $701,415
-3,972 Reduced 1.87%
208,982 $29.9 Million
Q1 2022

Apr 27, 2022

BUY
$126.46 - $235.05 $76,761 - $142,675
607 Added 0.29%
212,954 $36.7 Million
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $939,185 - $1.53 Million
-4,159 Reduced 1.92%
212,347 $53.9 Million
Q3 2021

Oct 20, 2021

BUY
$221.9 - $484.47 $48 Million - $105 Million
216,506 New
216,506 $83.3 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.